nodes	percent_of_prediction	percent_of_DWPC	metapath
Nortriptyline—HRH1—atherosclerosis	0.345	0.812	CbGaD
Nortriptyline—ALB—atherosclerosis	0.0796	0.188	CbGaD
Nortriptyline—ALB—Rosuvastatin—atherosclerosis	0.0316	0.0885	CbGbCtD
Nortriptyline—CYP3A5—Rosuvastatin—atherosclerosis	0.0254	0.0711	CbGbCtD
Nortriptyline—CYP3A5—Simvastatin—atherosclerosis	0.0236	0.0661	CbGbCtD
Nortriptyline—CYP3A5—Pravastatin—atherosclerosis	0.0231	0.0647	CbGbCtD
Nortriptyline—CYP3A5—Lovastatin—atherosclerosis	0.0231	0.0647	CbGbCtD
Nortriptyline—CYP2C19—Rosuvastatin—atherosclerosis	0.0205	0.0574	CbGbCtD
Nortriptyline—CYP2C19—Simvastatin—atherosclerosis	0.0191	0.0533	CbGbCtD
Nortriptyline—CYP2C19—Lovastatin—atherosclerosis	0.0186	0.0522	CbGbCtD
Nortriptyline—CYP2D6—Niacin—atherosclerosis	0.0183	0.0513	CbGbCtD
Nortriptyline—CYP2C9—Rosuvastatin—atherosclerosis	0.017	0.0477	CbGbCtD
Nortriptyline—CYP2C9—Simvastatin—atherosclerosis	0.0158	0.0444	CbGbCtD
Nortriptyline—CYP2C9—Lovastatin—atherosclerosis	0.0155	0.0434	CbGbCtD
Nortriptyline—CYP2C9—Pravastatin—atherosclerosis	0.0155	0.0434	CbGbCtD
Nortriptyline—CYP2D6—Simvastatin—atherosclerosis	0.0145	0.0406	CbGbCtD
Nortriptyline—CYP2D6—Pravastatin—atherosclerosis	0.0142	0.0397	CbGbCtD
Nortriptyline—CYP2D6—Lovastatin—atherosclerosis	0.0142	0.0397	CbGbCtD
Nortriptyline—CYP3A4—Ezetimibe—atherosclerosis	0.00991	0.0277	CbGbCtD
Nortriptyline—CYP3A4—Rosuvastatin—atherosclerosis	0.00991	0.0277	CbGbCtD
Nortriptyline—CYP3A4—Simvastatin—atherosclerosis	0.00921	0.0258	CbGbCtD
Nortriptyline—CYP3A4—Lovastatin—atherosclerosis	0.00902	0.0252	CbGbCtD
Nortriptyline—CYP3A4—Pravastatin—atherosclerosis	0.00902	0.0252	CbGbCtD
Nortriptyline—HTR2A—arteriole—atherosclerosis	0.000983	0.16	CbGeAlD
Nortriptyline—Phenindamine—HRH1—atherosclerosis	0.000851	0.177	CrCbGaD
Nortriptyline—Gynaecomastia—Simvastatin—atherosclerosis	0.000777	0.00735	CcSEcCtD
Nortriptyline—Hepatic function abnormal—Lovastatin—atherosclerosis	0.000771	0.00729	CcSEcCtD
Nortriptyline—Nightmare—Pravastatin—atherosclerosis	0.000758	0.00717	CcSEcCtD
Nortriptyline—Vascular purpura—Lovastatin—atherosclerosis	0.000753	0.00713	CcSEcCtD
Nortriptyline—Hepatic function abnormal—Simvastatin—atherosclerosis	0.000721	0.00682	CcSEcCtD
Nortriptyline—Hot flush—Ezetimibe—atherosclerosis	0.000706	0.00668	CcSEcCtD
Nortriptyline—Vascular purpura—Simvastatin—atherosclerosis	0.000704	0.00666	CcSEcCtD
Nortriptyline—Gynaecomastia—Pravastatin—atherosclerosis	0.000702	0.00664	CcSEcCtD
Nortriptyline—Menopausal symptoms—Ezetimibe—atherosclerosis	0.0007	0.00663	CcSEcCtD
Nortriptyline—Purpura—Lovastatin—atherosclerosis	0.000699	0.00661	CcSEcCtD
Nortriptyline—Azatadine—HRH1—atherosclerosis	0.000663	0.138	CrCbGaD
Nortriptyline—Hepatic function abnormal—Niacin—atherosclerosis	0.000662	0.00626	CcSEcCtD
Nortriptyline—Purpura—Simvastatin—atherosclerosis	0.000654	0.00619	CcSEcCtD
Nortriptyline—Hepatic function abnormal—Pravastatin—atherosclerosis	0.000652	0.00617	CcSEcCtD
Nortriptyline—Vascular purpura—Pravastatin—atherosclerosis	0.000637	0.00603	CcSEcCtD
Nortriptyline—Hot flush—Pravastatin—atherosclerosis	0.000609	0.00576	CcSEcCtD
Nortriptyline—Menopausal symptoms—Pravastatin—atherosclerosis	0.000604	0.00571	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Rosuvastatin—atherosclerosis	0.0006	0.00568	CcSEcCtD
Nortriptyline—Jaundice—Rosuvastatin—atherosclerosis	0.000597	0.00565	CcSEcCtD
Nortriptyline—Purpura—Pravastatin—atherosclerosis	0.000591	0.00559	CcSEcCtD
Nortriptyline—HTR2A—vein—atherosclerosis	0.000586	0.0952	CbGeAlD
Nortriptyline—Eosinophilia—Lovastatin—atherosclerosis	0.000576	0.00545	CcSEcCtD
Nortriptyline—Disturbance in sexual arousal—Niacin—atherosclerosis	0.000574	0.00543	CcSEcCtD
Nortriptyline—Eosinophilia—Ezetimibe—atherosclerosis	0.000565	0.00535	CcSEcCtD
Nortriptyline—Urinary retention—Niacin—atherosclerosis	0.00055	0.00521	CcSEcCtD
Nortriptyline—Hepatitis—Rosuvastatin—atherosclerosis	0.00055	0.0052	CcSEcCtD
Nortriptyline—Eosinophilia—Simvastatin—atherosclerosis	0.000539	0.0051	CcSEcCtD
Nortriptyline—Erectile dysfunction—Lovastatin—atherosclerosis	0.000536	0.00507	CcSEcCtD
Nortriptyline—Orthostatic hypotension—Niacin—atherosclerosis	0.000528	0.005	CcSEcCtD
Nortriptyline—Erectile dysfunction—Ezetimibe—atherosclerosis	0.000526	0.00498	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Lovastatin—atherosclerosis	0.000509	0.00482	CcSEcCtD
Nortriptyline—Erectile dysfunction—Simvastatin—atherosclerosis	0.000502	0.00475	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.000499	0.00472	CcSEcCtD
Nortriptyline—Jaundice—Ezetimibe—atherosclerosis	0.000496	0.0047	CcSEcCtD
Nortriptyline—Arrhythmia—Rosuvastatin—atherosclerosis	0.000491	0.00465	CcSEcCtD
Nortriptyline—Eosinophilia—Pravastatin—atherosclerosis	0.000487	0.00461	CcSEcCtD
Nortriptyline—Sweating increased—Pravastatin—atherosclerosis	0.00048	0.00454	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Simvastatin—atherosclerosis	0.000476	0.0045	CcSEcCtD
Nortriptyline—Jaundice—Simvastatin—atherosclerosis	0.000473	0.00448	CcSEcCtD
Nortriptyline—Hepatitis—Lovastatin—atherosclerosis	0.000466	0.00441	CcSEcCtD
Nortriptyline—Erectile dysfunction—Niacin—atherosclerosis	0.000461	0.00436	CcSEcCtD
Nortriptyline—Olopatadine—HRH1—atherosclerosis	0.00046	0.0958	CrCbGaD
Nortriptyline—Hepatitis—Ezetimibe—atherosclerosis	0.000457	0.00433	CcSEcCtD
Nortriptyline—Erectile dysfunction—Pravastatin—atherosclerosis	0.000453	0.00429	CcSEcCtD
Nortriptyline—Oedema peripheral—Ezetimibe—atherosclerosis	0.00045	0.00426	CcSEcCtD
Nortriptyline—Weight increased—Pravastatin—atherosclerosis	0.000448	0.00424	CcSEcCtD
Nortriptyline—Weight decreased—Pravastatin—atherosclerosis	0.000445	0.00421	CcSEcCtD
Nortriptyline—Hepatitis—Simvastatin—atherosclerosis	0.000436	0.00412	CcSEcCtD
Nortriptyline—Stomatitis—Niacin—atherosclerosis	0.000435	0.00411	CcSEcCtD
Nortriptyline—Jaundice—Niacin—atherosclerosis	0.000435	0.00411	CcSEcCtD
Nortriptyline—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000433	0.00409	CcSEcCtD
Nortriptyline—Flushing—Lovastatin—atherosclerosis	0.000432	0.00409	CcSEcCtD
Nortriptyline—Myocardial infarction—Pravastatin—atherosclerosis	0.00043	0.00407	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Pravastatin—atherosclerosis	0.00043	0.00407	CcSEcCtD
Nortriptyline—Jaundice—Pravastatin—atherosclerosis	0.000428	0.00405	CcSEcCtD
Nortriptyline—Sweating—Niacin—atherosclerosis	0.000427	0.00404	CcSEcCtD
Nortriptyline—Dimetindene—HRH1—atherosclerosis	0.000427	0.0891	CrCbGaD
Nortriptyline—Flushing—Ezetimibe—atherosclerosis	0.000424	0.00401	CcSEcCtD
Nortriptyline—Alopecia—Lovastatin—atherosclerosis	0.000412	0.0039	CcSEcCtD
Nortriptyline—Flushing—Simvastatin—atherosclerosis	0.000405	0.00383	CcSEcCtD
Nortriptyline—Alopecia—Ezetimibe—atherosclerosis	0.000404	0.00382	CcSEcCtD
Nortriptyline—Hepatitis—Niacin—atherosclerosis	0.0004	0.00379	CcSEcCtD
Nortriptyline—Hypoaesthesia—Niacin—atherosclerosis	0.000398	0.00377	CcSEcCtD
Nortriptyline—Dysgeusia—Lovastatin—atherosclerosis	0.000397	0.00376	CcSEcCtD
Nortriptyline—Oedema peripheral—Niacin—atherosclerosis	0.000394	0.00373	CcSEcCtD
Nortriptyline—Hepatitis—Pravastatin—atherosclerosis	0.000394	0.00373	CcSEcCtD
Nortriptyline—Confusional state—Rosuvastatin—atherosclerosis	0.000394	0.00373	CcSEcCtD
Nortriptyline—Hypoaesthesia—Pravastatin—atherosclerosis	0.000392	0.00371	CcSEcCtD
Nortriptyline—HTR2A—hindlimb—atherosclerosis	0.000389	0.0632	CbGeAlD
Nortriptyline—Alopecia—Simvastatin—atherosclerosis	0.000385	0.00364	CcSEcCtD
Nortriptyline—Epinastine—HRH1—atherosclerosis	0.000384	0.0799	CrCbGaD
Nortriptyline—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000383	0.00362	CcSEcCtD
Nortriptyline—Vision blurred—Lovastatin—atherosclerosis	0.000382	0.00362	CcSEcCtD
Nortriptyline—Tremor—Lovastatin—atherosclerosis	0.00038	0.0036	CcSEcCtD
Nortriptyline—Ill-defined disorder—Lovastatin—atherosclerosis	0.000376	0.00356	CcSEcCtD
Nortriptyline—Eye disorder—Niacin—atherosclerosis	0.000374	0.00354	CcSEcCtD
Nortriptyline—Tinnitus—Niacin—atherosclerosis	0.000373	0.00353	CcSEcCtD
Nortriptyline—Dysgeusia—Simvastatin—atherosclerosis	0.000372	0.00352	CcSEcCtD
Nortriptyline—Flushing—Niacin—atherosclerosis	0.000371	0.00351	CcSEcCtD
Nortriptyline—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000369	0.00349	CcSEcCtD
Nortriptyline—Tinnitus—Pravastatin—atherosclerosis	0.000367	0.00348	CcSEcCtD
Nortriptyline—Malaise—Lovastatin—atherosclerosis	0.000366	0.00346	CcSEcCtD
Nortriptyline—Flushing—Pravastatin—atherosclerosis	0.000366	0.00346	CcSEcCtD
Nortriptyline—Leukopenia—Lovastatin—atherosclerosis	0.000363	0.00344	CcSEcCtD
Nortriptyline—Malaise—Ezetimibe—atherosclerosis	0.000359	0.0034	CcSEcCtD
Nortriptyline—Vision blurred—Simvastatin—atherosclerosis	0.000358	0.00338	CcSEcCtD
Nortriptyline—Arrhythmia—Niacin—atherosclerosis	0.000358	0.00338	CcSEcCtD
Nortriptyline—Tremor—Simvastatin—atherosclerosis	0.000355	0.00336	CcSEcCtD
Nortriptyline—Alopecia—Niacin—atherosclerosis	0.000354	0.00335	CcSEcCtD
Nortriptyline—Insomnia—Rosuvastatin—atherosclerosis	0.000353	0.00334	CcSEcCtD
Nortriptyline—Ill-defined disorder—Simvastatin—atherosclerosis	0.000352	0.00333	CcSEcCtD
Nortriptyline—Arrhythmia—Pravastatin—atherosclerosis	0.000352	0.00333	CcSEcCtD
Nortriptyline—Palpitations—Ezetimibe—atherosclerosis	0.000352	0.00333	CcSEcCtD
Nortriptyline—Paraesthesia—Rosuvastatin—atherosclerosis	0.000351	0.00332	CcSEcCtD
Nortriptyline—Alopecia—Pravastatin—atherosclerosis	0.000348	0.0033	CcSEcCtD
Nortriptyline—Anxiety—Lovastatin—atherosclerosis	0.000344	0.00326	CcSEcCtD
Nortriptyline—Dyspepsia—Rosuvastatin—atherosclerosis	0.000344	0.00325	CcSEcCtD
Nortriptyline—Hypertension—Ezetimibe—atherosclerosis	0.000344	0.00325	CcSEcCtD
Nortriptyline—Malaise—Simvastatin—atherosclerosis	0.000342	0.00324	CcSEcCtD
Nortriptyline—Tension—Niacin—atherosclerosis	0.000342	0.00324	CcSEcCtD
Nortriptyline—Discomfort—Lovastatin—atherosclerosis	0.000341	0.00323	CcSEcCtD
Nortriptyline—Leukopenia—Simvastatin—atherosclerosis	0.00034	0.00321	CcSEcCtD
Nortriptyline—Nervousness—Niacin—atherosclerosis	0.000338	0.0032	CcSEcCtD
Nortriptyline—Dry mouth—Lovastatin—atherosclerosis	0.000338	0.0032	CcSEcCtD
Nortriptyline—Tension—Pravastatin—atherosclerosis	0.000337	0.00319	CcSEcCtD
Nortriptyline—Dysgeusia—Pravastatin—atherosclerosis	0.000336	0.00318	CcSEcCtD
Nortriptyline—Discomfort—Ezetimibe—atherosclerosis	0.000335	0.00317	CcSEcCtD
Nortriptyline—Constipation—Rosuvastatin—atherosclerosis	0.000334	0.00316	CcSEcCtD
Nortriptyline—HTR2A—appendage—atherosclerosis	0.000334	0.0543	CbGeAlD
Nortriptyline—Confusional state—Lovastatin—atherosclerosis	0.000334	0.00316	CcSEcCtD
Nortriptyline—Nervousness—Pravastatin—atherosclerosis	0.000333	0.00315	CcSEcCtD
Nortriptyline—Dry mouth—Ezetimibe—atherosclerosis	0.000331	0.00313	CcSEcCtD
Nortriptyline—Maprotiline—HRH1—atherosclerosis	0.00033	0.0688	CrCbGaD
Nortriptyline—Vision blurred—Niacin—atherosclerosis	0.000328	0.00311	CcSEcCtD
Nortriptyline—Confusional state—Ezetimibe—atherosclerosis	0.000327	0.0031	CcSEcCtD
Nortriptyline—Thrombocytopenia—Lovastatin—atherosclerosis	0.000324	0.00307	CcSEcCtD
Nortriptyline—Vision blurred—Pravastatin—atherosclerosis	0.000323	0.00306	CcSEcCtD
Nortriptyline—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000322	0.00305	CcSEcCtD
Nortriptyline—Anxiety—Simvastatin—atherosclerosis	0.000322	0.00305	CcSEcCtD
Nortriptyline—Tremor—Pravastatin—atherosclerosis	0.000321	0.00304	CcSEcCtD
Nortriptyline—Discomfort—Simvastatin—atherosclerosis	0.000319	0.00302	CcSEcCtD
Nortriptyline—Ill-defined disorder—Pravastatin—atherosclerosis	0.000318	0.00301	CcSEcCtD
Nortriptyline—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000318	0.00301	CcSEcCtD
Nortriptyline—Anorexia—Lovastatin—atherosclerosis	0.000316	0.00299	CcSEcCtD
Nortriptyline—Syncope—Niacin—atherosclerosis	0.000312	0.00296	CcSEcCtD
Nortriptyline—Confusional state—Simvastatin—atherosclerosis	0.000312	0.00295	CcSEcCtD
Nortriptyline—Leukopenia—Niacin—atherosclerosis	0.000312	0.00295	CcSEcCtD
Nortriptyline—Urticaria—Rosuvastatin—atherosclerosis	0.00031	0.00294	CcSEcCtD
Nortriptyline—Oedema—Simvastatin—atherosclerosis	0.00031	0.00293	CcSEcCtD
Nortriptyline—Malaise—Pravastatin—atherosclerosis	0.000309	0.00293	CcSEcCtD
Nortriptyline—Abdominal pain—Rosuvastatin—atherosclerosis	0.000309	0.00292	CcSEcCtD
Nortriptyline—Palpitations—Niacin—atherosclerosis	0.000308	0.00291	CcSEcCtD
Nortriptyline—Leukopenia—Pravastatin—atherosclerosis	0.000307	0.00291	CcSEcCtD
Nortriptyline—Loss of consciousness—Niacin—atherosclerosis	0.000306	0.0029	CcSEcCtD
Nortriptyline—Thrombocytopenia—Simvastatin—atherosclerosis	0.000303	0.00287	CcSEcCtD
Nortriptyline—Insomnia—Lovastatin—atherosclerosis	0.000299	0.00283	CcSEcCtD
Nortriptyline—Paraesthesia—Lovastatin—atherosclerosis	0.000297	0.00281	CcSEcCtD
Nortriptyline—Hypertension—Pravastatin—atherosclerosis	0.000296	0.0028	CcSEcCtD
Nortriptyline—Anorexia—Simvastatin—atherosclerosis	0.000295	0.00279	CcSEcCtD
Nortriptyline—Insomnia—Ezetimibe—atherosclerosis	0.000294	0.00278	CcSEcCtD
Nortriptyline—Cyproheptadine—HRH1—atherosclerosis	0.000293	0.061	CrCbGaD
Nortriptyline—Paraesthesia—Ezetimibe—atherosclerosis	0.000292	0.00276	CcSEcCtD
Nortriptyline—Dyspepsia—Lovastatin—atherosclerosis	0.000291	0.00276	CcSEcCtD
Nortriptyline—Anxiety—Pravastatin—atherosclerosis	0.000291	0.00275	CcSEcCtD
Nortriptyline—Dry mouth—Niacin—atherosclerosis	0.00029	0.00275	CcSEcCtD
Nortriptyline—Discomfort—Pravastatin—atherosclerosis	0.000289	0.00273	CcSEcCtD
Nortriptyline—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000288	0.00272	CcSEcCtD
Nortriptyline—Decreased appetite—Lovastatin—atherosclerosis	0.000288	0.00272	CcSEcCtD
Nortriptyline—Dyspepsia—Ezetimibe—atherosclerosis	0.000286	0.0027	CcSEcCtD
Nortriptyline—Fatigue—Lovastatin—atherosclerosis	0.000285	0.0027	CcSEcCtD
Nortriptyline—Oedema—Niacin—atherosclerosis	0.000284	0.00269	CcSEcCtD
Nortriptyline—Constipation—Lovastatin—atherosclerosis	0.000283	0.00268	CcSEcCtD
Nortriptyline—Confusional state—Pravastatin—atherosclerosis	0.000282	0.00267	CcSEcCtD
Nortriptyline—Decreased appetite—Ezetimibe—atherosclerosis	0.000282	0.00267	CcSEcCtD
Nortriptyline—Asthenia—Rosuvastatin—atherosclerosis	0.00028	0.00265	CcSEcCtD
Nortriptyline—Insomnia—Simvastatin—atherosclerosis	0.00028	0.00265	CcSEcCtD
Nortriptyline—Oedema—Pravastatin—atherosclerosis	0.00028	0.00265	CcSEcCtD
Nortriptyline—Fatigue—Ezetimibe—atherosclerosis	0.00028	0.00265	CcSEcCtD
Nortriptyline—Shock—Niacin—atherosclerosis	0.00028	0.00265	CcSEcCtD
Nortriptyline—Paraesthesia—Simvastatin—atherosclerosis	0.000278	0.00263	CcSEcCtD
Nortriptyline—Constipation—Ezetimibe—atherosclerosis	0.000278	0.00263	CcSEcCtD
Nortriptyline—Tachycardia—Niacin—atherosclerosis	0.000278	0.00263	CcSEcCtD
Nortriptyline—Pruritus—Rosuvastatin—atherosclerosis	0.000276	0.00262	CcSEcCtD
Nortriptyline—Hyperhidrosis—Niacin—atherosclerosis	0.000275	0.0026	CcSEcCtD
Nortriptyline—Thrombocytopenia—Pravastatin—atherosclerosis	0.000274	0.00259	CcSEcCtD
Nortriptyline—Feeling abnormal—Lovastatin—atherosclerosis	0.000273	0.00258	CcSEcCtD
Nortriptyline—Dyspepsia—Simvastatin—atherosclerosis	0.000273	0.00258	CcSEcCtD
Nortriptyline—Anorexia—Niacin—atherosclerosis	0.000271	0.00256	CcSEcCtD
Nortriptyline—Hyperhidrosis—Pravastatin—atherosclerosis	0.000271	0.00256	CcSEcCtD
Nortriptyline—Decreased appetite—Simvastatin—atherosclerosis	0.000269	0.00255	CcSEcCtD
Nortriptyline—Feeling abnormal—Ezetimibe—atherosclerosis	0.000268	0.00253	CcSEcCtD
Nortriptyline—Diarrhoea—Rosuvastatin—atherosclerosis	0.000267	0.00253	CcSEcCtD
Nortriptyline—Fatigue—Simvastatin—atherosclerosis	0.000267	0.00253	CcSEcCtD
Nortriptyline—Anorexia—Pravastatin—atherosclerosis	0.000267	0.00253	CcSEcCtD
Nortriptyline—Hypotension—Niacin—atherosclerosis	0.000266	0.00251	CcSEcCtD
Nortriptyline—Constipation—Simvastatin—atherosclerosis	0.000265	0.00251	CcSEcCtD
Nortriptyline—PTGS1—artery—atherosclerosis	0.000265	0.043	CbGeAlD
Nortriptyline—Urticaria—Lovastatin—atherosclerosis	0.000263	0.00249	CcSEcCtD
Nortriptyline—Abdominal pain—Lovastatin—atherosclerosis	0.000262	0.00248	CcSEcCtD
Nortriptyline—Body temperature increased—Lovastatin—atherosclerosis	0.000262	0.00248	CcSEcCtD
Nortriptyline—Dizziness—Rosuvastatin—atherosclerosis	0.000258	0.00244	CcSEcCtD
Nortriptyline—Urticaria—Ezetimibe—atherosclerosis	0.000258	0.00244	CcSEcCtD
Nortriptyline—Insomnia—Niacin—atherosclerosis	0.000257	0.00243	CcSEcCtD
Nortriptyline—Abdominal pain—Ezetimibe—atherosclerosis	0.000257	0.00243	CcSEcCtD
Nortriptyline—Body temperature increased—Ezetimibe—atherosclerosis	0.000257	0.00243	CcSEcCtD
Nortriptyline—Paraesthesia—Niacin—atherosclerosis	0.000255	0.00242	CcSEcCtD
Nortriptyline—Feeling abnormal—Simvastatin—atherosclerosis	0.000255	0.00241	CcSEcCtD
Nortriptyline—Insomnia—Pravastatin—atherosclerosis	0.000253	0.0024	CcSEcCtD
Nortriptyline—Somnolence—Niacin—atherosclerosis	0.000253	0.00239	CcSEcCtD
Nortriptyline—Paraesthesia—Pravastatin—atherosclerosis	0.000251	0.00238	CcSEcCtD
Nortriptyline—Dyspepsia—Niacin—atherosclerosis	0.00025	0.00237	CcSEcCtD
Nortriptyline—Decreased appetite—Niacin—atherosclerosis	0.000247	0.00234	CcSEcCtD
Nortriptyline—Dyspepsia—Pravastatin—atherosclerosis	0.000246	0.00233	CcSEcCtD
Nortriptyline—Rash—Rosuvastatin—atherosclerosis	0.000246	0.00233	CcSEcCtD
Nortriptyline—Dermatitis—Rosuvastatin—atherosclerosis	0.000246	0.00233	CcSEcCtD
Nortriptyline—Urticaria—Simvastatin—atherosclerosis	0.000246	0.00233	CcSEcCtD
Nortriptyline—Body temperature increased—Simvastatin—atherosclerosis	0.000245	0.00232	CcSEcCtD
Nortriptyline—Abdominal pain—Simvastatin—atherosclerosis	0.000245	0.00232	CcSEcCtD
Nortriptyline—Headache—Rosuvastatin—atherosclerosis	0.000245	0.00232	CcSEcCtD
Nortriptyline—Hypersensitivity—Lovastatin—atherosclerosis	0.000244	0.00231	CcSEcCtD
Nortriptyline—Decreased appetite—Pravastatin—atherosclerosis	0.000243	0.0023	CcSEcCtD
Nortriptyline—Fatigue—Pravastatin—atherosclerosis	0.000241	0.00228	CcSEcCtD
Nortriptyline—Constipation—Pravastatin—atherosclerosis	0.000239	0.00227	CcSEcCtD
Nortriptyline—Hypersensitivity—Ezetimibe—atherosclerosis	0.000239	0.00226	CcSEcCtD
Nortriptyline—HTR2A—artery—atherosclerosis	0.000239	0.0388	CbGeAlD
Nortriptyline—Asthenia—Lovastatin—atherosclerosis	0.000238	0.00225	CcSEcCtD
Nortriptyline—Pruritus—Lovastatin—atherosclerosis	0.000234	0.00222	CcSEcCtD
Nortriptyline—Asthenia—Ezetimibe—atherosclerosis	0.000233	0.0022	CcSEcCtD
Nortriptyline—Nausea—Rosuvastatin—atherosclerosis	0.000232	0.0022	CcSEcCtD
Nortriptyline—Feeling abnormal—Pravastatin—atherosclerosis	0.000231	0.00218	CcSEcCtD
Nortriptyline—Pruritus—Ezetimibe—atherosclerosis	0.00023	0.00217	CcSEcCtD
Nortriptyline—Hypersensitivity—Simvastatin—atherosclerosis	0.000228	0.00216	CcSEcCtD
Nortriptyline—Diarrhoea—Lovastatin—atherosclerosis	0.000227	0.00214	CcSEcCtD
Nortriptyline—Urticaria—Niacin—atherosclerosis	0.000226	0.00214	CcSEcCtD
Nortriptyline—Body temperature increased—Niacin—atherosclerosis	0.000225	0.00213	CcSEcCtD
Nortriptyline—Abdominal pain—Niacin—atherosclerosis	0.000225	0.00213	CcSEcCtD
Nortriptyline—PTGS1—endothelium—atherosclerosis	0.000223	0.0363	CbGeAlD
Nortriptyline—Urticaria—Pravastatin—atherosclerosis	0.000222	0.0021	CcSEcCtD
Nortriptyline—Asthenia—Simvastatin—atherosclerosis	0.000222	0.0021	CcSEcCtD
Nortriptyline—Diarrhoea—Ezetimibe—atherosclerosis	0.000222	0.0021	CcSEcCtD
Nortriptyline—Mianserin—HRH1—atherosclerosis	0.000222	0.0463	CrCbGaD
Nortriptyline—Body temperature increased—Pravastatin—atherosclerosis	0.000221	0.00209	CcSEcCtD
Nortriptyline—Abdominal pain—Pravastatin—atherosclerosis	0.000221	0.00209	CcSEcCtD
Nortriptyline—Pruritus—Simvastatin—atherosclerosis	0.000219	0.00207	CcSEcCtD
Nortriptyline—Dizziness—Lovastatin—atherosclerosis	0.000219	0.00207	CcSEcCtD
Nortriptyline—Dizziness—Ezetimibe—atherosclerosis	0.000215	0.00203	CcSEcCtD
Nortriptyline—Diarrhoea—Simvastatin—atherosclerosis	0.000212	0.002	CcSEcCtD
Nortriptyline—Vomiting—Lovastatin—atherosclerosis	0.000211	0.00199	CcSEcCtD
Nortriptyline—Hypersensitivity—Niacin—atherosclerosis	0.000209	0.00198	CcSEcCtD
Nortriptyline—Rash—Lovastatin—atherosclerosis	0.000209	0.00198	CcSEcCtD
Nortriptyline—Dermatitis—Lovastatin—atherosclerosis	0.000209	0.00197	CcSEcCtD
Nortriptyline—Headache—Lovastatin—atherosclerosis	0.000207	0.00196	CcSEcCtD
Nortriptyline—Vomiting—Ezetimibe—atherosclerosis	0.000206	0.00195	CcSEcCtD
Nortriptyline—Hypersensitivity—Pravastatin—atherosclerosis	0.000206	0.00195	CcSEcCtD
Nortriptyline—PTGS1—blood vessel—atherosclerosis	0.000206	0.0335	CbGeAlD
Nortriptyline—Dizziness—Simvastatin—atherosclerosis	0.000205	0.00194	CcSEcCtD
Nortriptyline—Rash—Ezetimibe—atherosclerosis	0.000205	0.00194	CcSEcCtD
Nortriptyline—Dermatitis—Ezetimibe—atherosclerosis	0.000205	0.00194	CcSEcCtD
Nortriptyline—Asthenia—Niacin—atherosclerosis	0.000204	0.00193	CcSEcCtD
Nortriptyline—Headache—Ezetimibe—atherosclerosis	0.000203	0.00193	CcSEcCtD
Nortriptyline—Chlorprothixene—HRH1—atherosclerosis	0.000202	0.0421	CrCbGaD
Nortriptyline—HTR2A—endothelium—atherosclerosis	0.000202	0.0327	CbGeAlD
Nortriptyline—Pruritus—Niacin—atherosclerosis	0.000201	0.0019	CcSEcCtD
Nortriptyline—Asthenia—Pravastatin—atherosclerosis	0.000201	0.0019	CcSEcCtD
Nortriptyline—Pruritus—Pravastatin—atherosclerosis	0.000198	0.00187	CcSEcCtD
Nortriptyline—Vomiting—Simvastatin—atherosclerosis	0.000197	0.00186	CcSEcCtD
Nortriptyline—Nausea—Lovastatin—atherosclerosis	0.000197	0.00186	CcSEcCtD
Nortriptyline—Rash—Simvastatin—atherosclerosis	0.000195	0.00185	CcSEcCtD
Nortriptyline—Dermatitis—Simvastatin—atherosclerosis	0.000195	0.00185	CcSEcCtD
Nortriptyline—Diarrhoea—Niacin—atherosclerosis	0.000195	0.00184	CcSEcCtD
Nortriptyline—Headache—Simvastatin—atherosclerosis	0.000194	0.00184	CcSEcCtD
Nortriptyline—Nausea—Ezetimibe—atherosclerosis	0.000193	0.00183	CcSEcCtD
Nortriptyline—Diarrhoea—Pravastatin—atherosclerosis	0.000192	0.00181	CcSEcCtD
Nortriptyline—Dizziness—Niacin—atherosclerosis	0.000188	0.00178	CcSEcCtD
Nortriptyline—Trimipramine—HRH1—atherosclerosis	0.000187	0.0389	CrCbGaD
Nortriptyline—HTR2A—blood vessel—atherosclerosis	0.000186	0.0302	CbGeAlD
Nortriptyline—Dizziness—Pravastatin—atherosclerosis	0.000185	0.00175	CcSEcCtD
Nortriptyline—Nausea—Simvastatin—atherosclerosis	0.000184	0.00174	CcSEcCtD
Nortriptyline—Vomiting—Niacin—atherosclerosis	0.000181	0.00171	CcSEcCtD
Nortriptyline—Rash—Niacin—atherosclerosis	0.000179	0.0017	CcSEcCtD
Nortriptyline—Dermatitis—Niacin—atherosclerosis	0.000179	0.00169	CcSEcCtD
Nortriptyline—Headache—Niacin—atherosclerosis	0.000178	0.00169	CcSEcCtD
Nortriptyline—Vomiting—Pravastatin—atherosclerosis	0.000178	0.00168	CcSEcCtD
Nortriptyline—Doxepin—HRH1—atherosclerosis	0.000178	0.0371	CrCbGaD
Nortriptyline—Rash—Pravastatin—atherosclerosis	0.000177	0.00167	CcSEcCtD
Nortriptyline—Dermatitis—Pravastatin—atherosclerosis	0.000176	0.00167	CcSEcCtD
Nortriptyline—Headache—Pravastatin—atherosclerosis	0.000175	0.00166	CcSEcCtD
Nortriptyline—CHRM2—cardiovascular system—atherosclerosis	0.000172	0.0279	CbGeAlD
Nortriptyline—Nausea—Niacin—atherosclerosis	0.000169	0.0016	CcSEcCtD
Nortriptyline—Nausea—Pravastatin—atherosclerosis	0.000166	0.00157	CcSEcCtD
Nortriptyline—Desipramine—HRH1—atherosclerosis	0.000163	0.034	CrCbGaD
Nortriptyline—CHRM1—cardiovascular system—atherosclerosis	0.000156	0.0254	CbGeAlD
Nortriptyline—HTR1A—cardiovascular system—atherosclerosis	0.000139	0.0226	CbGeAlD
Nortriptyline—Imipramine—HRH1—atherosclerosis	0.000139	0.0289	CrCbGaD
Nortriptyline—Amitriptyline—HRH1—atherosclerosis	0.000138	0.0287	CrCbGaD
Nortriptyline—ADRA1A—cardiovascular system—atherosclerosis	0.000128	0.0208	CbGeAlD
Nortriptyline—CHRM3—adipose tissue—atherosclerosis	0.000123	0.02	CbGeAlD
Nortriptyline—HRH1—connective tissue—atherosclerosis	0.000114	0.0185	CbGeAlD
Nortriptyline—ORM1—liver—atherosclerosis	0.000114	0.0185	CbGeAlD
Nortriptyline—ADRA1A—adipose tissue—atherosclerosis	0.000113	0.0184	CbGeAlD
Nortriptyline—PTGS1—connective tissue—atherosclerosis	0.000106	0.0172	CbGeAlD
Nortriptyline—CYP2C9—cardiovascular system—atherosclerosis	0.000101	0.0164	CbGeAlD
Nortriptyline—ALB—liver—atherosclerosis	9.98e-05	0.0162	CbGeAlD
Nortriptyline—CYP2E1—cardiovascular system—atherosclerosis	9.54e-05	0.0155	CbGeAlD
Nortriptyline—HTR2A—connective tissue—atherosclerosis	9.53e-05	0.0155	CbGeAlD
Nortriptyline—PTGS1—cardiovascular system—atherosclerosis	9.19e-05	0.0149	CbGeAlD
Nortriptyline—CYP3A5—adipose tissue—atherosclerosis	9.02e-05	0.0147	CbGeAlD
Nortriptyline—HRH1—adipose tissue—atherosclerosis	8.76e-05	0.0142	CbGeAlD
Nortriptyline—HTR2A—cardiovascular system—atherosclerosis	8.29e-05	0.0135	CbGeAlD
Nortriptyline—Oxcarbazepine—ALB—atherosclerosis	8.16e-05	0.017	CrCbGaD
Nortriptyline—PTGS1—adipose tissue—atherosclerosis	8.11e-05	0.0132	CbGeAlD
Nortriptyline—CYP2C19—liver—atherosclerosis	8.03e-05	0.013	CbGeAlD
Nortriptyline—ADRA1A—liver—atherosclerosis	7.93e-05	0.0129	CbGeAlD
Nortriptyline—CYP1A2—liver—atherosclerosis	6.56e-05	0.0107	CbGeAlD
Nortriptyline—CYP3A5—liver—atherosclerosis	6.33e-05	0.0103	CbGeAlD
Nortriptyline—CYP2C9—liver—atherosclerosis	6.23e-05	0.0101	CbGeAlD
Nortriptyline—CYP2E1—liver—atherosclerosis	5.9e-05	0.00959	CbGeAlD
Nortriptyline—HTR2A—liver—atherosclerosis	5.13e-05	0.00833	CbGeAlD
Nortriptyline—CYP3A4—liver—atherosclerosis	4.75e-05	0.00771	CbGeAlD
Nortriptyline—Clomipramine—ALB—atherosclerosis	4.69e-05	0.00977	CrCbGaD
Nortriptyline—CYP2D6—liver—atherosclerosis	4.67e-05	0.00759	CbGeAlD
Nortriptyline—Amitriptyline—ALB—atherosclerosis	3.18e-05	0.00662	CrCbGaD
Nortriptyline—CHRM3—Signaling Pathways—SERPINE1—atherosclerosis	2.78e-06	2.73e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—MAPK8—atherosclerosis	2.77e-06	2.73e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PIK3CG—atherosclerosis	2.77e-06	2.72e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—TGFB1—atherosclerosis	2.77e-06	2.72e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—AKT1—atherosclerosis	2.76e-06	2.72e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—APOE—atherosclerosis	2.75e-06	2.71e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—SERPINE1—atherosclerosis	2.75e-06	2.71e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—CXCL8—atherosclerosis	2.75e-06	2.7e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—SERPINE1—atherosclerosis	2.74e-06	2.7e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—CXCL8—atherosclerosis	2.73e-06	2.69e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—CAV1—atherosclerosis	2.73e-06	2.68e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—VEGFA—atherosclerosis	2.72e-06	2.68e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—APOA1—atherosclerosis	2.72e-06	2.68e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—MTHFR—atherosclerosis	2.72e-06	2.67e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—NOS3—atherosclerosis	2.72e-06	2.67e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—MTHFR—atherosclerosis	2.69e-06	2.65e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—STAT3—atherosclerosis	2.69e-06	2.65e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—MAPK3—atherosclerosis	2.69e-06	2.64e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—APOB—atherosclerosis	2.68e-06	2.63e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—NOS3—atherosclerosis	2.67e-06	2.63e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—NOS3—atherosclerosis	2.67e-06	2.63e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PPARG—atherosclerosis	2.67e-06	2.63e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—NOS3—atherosclerosis	2.67e-06	2.62e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PPARA—atherosclerosis	2.67e-06	2.62e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—NOS3—atherosclerosis	2.67e-06	2.62e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—NOS3—atherosclerosis	2.66e-06	2.62e-05	CbGpPWpGaD
Nortriptyline—HTR1A—GPCR downstream signaling—AKT1—atherosclerosis	2.65e-06	2.61e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—NOS3—atherosclerosis	2.65e-06	2.61e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PPARA—atherosclerosis	2.64e-06	2.6e-05	CbGpPWpGaD
Nortriptyline—HTR2C—GPCR downstream signaling—AKT1—atherosclerosis	2.64e-06	2.6e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—NOS3—atherosclerosis	2.63e-06	2.58e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—INS—atherosclerosis	2.62e-06	2.58e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—NOS3—atherosclerosis	2.62e-06	2.58e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CXCL8—atherosclerosis	2.61e-06	2.57e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—IL6—atherosclerosis	2.61e-06	2.57e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—TGFB1—atherosclerosis	2.61e-06	2.57e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—GSTM1—atherosclerosis	2.61e-06	2.56e-05	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—AKT1—atherosclerosis	2.6e-06	2.56e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—IL6—atherosclerosis	2.6e-06	2.56e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—AGT—atherosclerosis	2.58e-06	2.54e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—MAPK3—atherosclerosis	2.57e-06	2.53e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—AGT—atherosclerosis	2.56e-06	2.52e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—VEGFA—atherosclerosis	2.56e-06	2.52e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—LPL—atherosclerosis	2.56e-06	2.52e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—STAT3—atherosclerosis	2.53e-06	2.49e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—APOE—atherosclerosis	2.53e-06	2.49e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—GPCR downstream signaling—AKT1—atherosclerosis	2.53e-06	2.48e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—ABCA1—atherosclerosis	2.52e-06	2.47e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—APOE—atherosclerosis	2.51e-06	2.47e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—CAV1—atherosclerosis	2.51e-06	2.47e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—APOA1—atherosclerosis	2.5e-06	2.46e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—TGFB1—atherosclerosis	2.5e-06	2.46e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—GPX1—atherosclerosis	2.5e-06	2.45e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—IL6—atherosclerosis	2.49e-06	2.45e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—CAV1—atherosclerosis	2.49e-06	2.45e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—MMP9—atherosclerosis	2.48e-06	2.44e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PIK3CG—atherosclerosis	2.48e-06	2.44e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—APOA1—atherosclerosis	2.48e-06	2.44e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—MMP9—atherosclerosis	2.47e-06	2.43e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—NFKB1—atherosclerosis	2.46e-06	2.42e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—NFKB1—atherosclerosis	2.44e-06	2.4e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—PTGS2—atherosclerosis	2.44e-06	2.4e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—PTGS2—atherosclerosis	2.44e-06	2.4e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CD36—atherosclerosis	2.43e-06	2.39e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—MAPK3—atherosclerosis	2.42e-06	2.38e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—MAPK8—atherosclerosis	2.42e-06	2.38e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CXCL8—atherosclerosis	2.41e-06	2.37e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—AKT1—atherosclerosis	2.41e-06	2.37e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—MAPK8—atherosclerosis	2.4e-06	2.36e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PPARG—atherosclerosis	2.4e-06	2.36e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—AKT1—atherosclerosis	2.4e-06	2.36e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CXCL8—atherosclerosis	2.37e-06	2.33e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CXCL8—atherosclerosis	2.37e-06	2.33e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—MMP9—atherosclerosis	2.37e-06	2.33e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CXCL8—atherosclerosis	2.36e-06	2.32e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CXCL8—atherosclerosis	2.35e-06	2.31e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—INS—atherosclerosis	2.35e-06	2.31e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—TGFB1—atherosclerosis	2.35e-06	2.31e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—NFKB1—atherosclerosis	2.34e-06	2.3e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CXCL8—atherosclerosis	2.33e-06	2.29e-05	CbGpPWpGaD
Nortriptyline—DRD2—GPCR downstream signaling—AKT1—atherosclerosis	2.33e-06	2.29e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CXCL8—atherosclerosis	2.32e-06	2.28e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—MTHFR—atherosclerosis	2.3e-06	2.27e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—MAPK8—atherosclerosis	2.3e-06	2.26e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—NOS3—atherosclerosis	2.3e-06	2.26e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—AKT1—atherosclerosis	2.29e-06	2.26e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—IL6—atherosclerosis	2.29e-06	2.25e-05	CbGpPWpGaD
Nortriptyline—HTR2A—GPCR downstream signaling—AKT1—atherosclerosis	2.29e-06	2.25e-05	CbGpPWpGaD
Nortriptyline—HRH1—GPCR downstream signaling—AKT1—atherosclerosis	2.29e-06	2.25e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PIK3CG—atherosclerosis	2.28e-06	2.25e-05	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR downstream signaling—AKT1—atherosclerosis	2.28e-06	2.24e-05	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR downstream signaling—AKT1—atherosclerosis	2.27e-06	2.23e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PIK3CG—atherosclerosis	2.26e-06	2.23e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PPARA—atherosclerosis	2.26e-06	2.22e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—IL6—atherosclerosis	2.26e-06	2.22e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—IL6—atherosclerosis	2.25e-06	2.21e-05	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR downstream signaling—AKT1—atherosclerosis	2.25e-06	2.21e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR downstream signaling—AKT1—atherosclerosis	2.24e-06	2.21e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—IL6—atherosclerosis	2.24e-06	2.21e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—IL6—atherosclerosis	2.24e-06	2.2e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—VEGFA—atherosclerosis	2.23e-06	2.19e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—VEGFA—atherosclerosis	2.22e-06	2.18e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—IL6—atherosclerosis	2.21e-06	2.18e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—IL6—atherosclerosis	2.21e-06	2.17e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—STAT3—atherosclerosis	2.21e-06	2.17e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PPARG—atherosclerosis	2.2e-06	2.17e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—STAT3—atherosclerosis	2.2e-06	2.16e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—AGT—atherosclerosis	2.19e-06	2.15e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PPARG—atherosclerosis	2.19e-06	2.15e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—MMP9—atherosclerosis	2.18e-06	2.14e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—INS—atherosclerosis	2.16e-06	2.13e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—HMOX1—atherosclerosis	2.16e-06	2.12e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—NFKB1—atherosclerosis	2.16e-06	2.12e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—ALB—atherosclerosis	2.15e-06	2.12e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—MMP9—atherosclerosis	2.15e-06	2.11e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—APOE—atherosclerosis	2.14e-06	2.11e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—INS—atherosclerosis	2.14e-06	2.11e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—MMP9—atherosclerosis	2.14e-06	2.11e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—MMP9—atherosclerosis	2.13e-06	2.1e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—MMP9—atherosclerosis	2.13e-06	2.09e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CAV1—atherosclerosis	2.12e-06	2.09e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—VEGFA—atherosclerosis	2.12e-06	2.09e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—NFKB1—atherosclerosis	2.12e-06	2.09e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—MAPK8—atherosclerosis	2.12e-06	2.09e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—APOA1—atherosclerosis	2.12e-06	2.08e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—NFKB1—atherosclerosis	2.12e-06	2.08e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—AKT1—atherosclerosis	2.11e-06	2.08e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—NFKB1—atherosclerosis	2.11e-06	2.08e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—MAPK3—atherosclerosis	2.11e-06	2.08e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—MMP9—atherosclerosis	2.11e-06	2.07e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—NFKB1—atherosclerosis	2.1e-06	2.07e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—STAT3—atherosclerosis	2.1e-06	2.07e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—MMP9—atherosclerosis	2.1e-06	2.07e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PTGS2—atherosclerosis	2.1e-06	2.07e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—MAPK3—atherosclerosis	2.1e-06	2.06e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—MAPK8—atherosclerosis	2.09e-06	2.05e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—NFKB1—atherosclerosis	2.08e-06	2.05e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—IL6—atherosclerosis	2.08e-06	2.05e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—MAPK8—atherosclerosis	2.08e-06	2.05e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—AKT1—atherosclerosis	2.08e-06	2.05e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—NFKB1—atherosclerosis	2.08e-06	2.04e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—AKT1—atherosclerosis	2.08e-06	2.04e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—MAPK8—atherosclerosis	2.08e-06	2.04e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—AKT1—atherosclerosis	2.07e-06	2.04e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—MAPK8—atherosclerosis	2.07e-06	2.04e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—APOB—atherosclerosis	2.07e-06	2.03e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—AKT1—atherosclerosis	2.06e-06	2.03e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—NOS3—atherosclerosis	2.06e-06	2.03e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—MAPK8—atherosclerosis	2.05e-06	2.02e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—TGFB1—atherosclerosis	2.05e-06	2.01e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—AKT1—atherosclerosis	2.04e-06	2.01e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—MAPK8—atherosclerosis	2.04e-06	2.01e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—AKT1—atherosclerosis	2.04e-06	2e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—TGFB1—atherosclerosis	2.04e-06	2e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GSTM1—atherosclerosis	2.01e-06	1.98e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—MAPK3—atherosclerosis	2.01e-06	1.98e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—ALB—atherosclerosis	1.98e-06	1.95e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—LPL—atherosclerosis	1.97e-06	1.94e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—IL6—atherosclerosis	1.97e-06	1.93e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—ALB—atherosclerosis	1.96e-06	1.93e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—VEGFA—atherosclerosis	1.96e-06	1.93e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—TGFB1—atherosclerosis	1.95e-06	1.92e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—STAT3—atherosclerosis	1.94e-06	1.91e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PIK3CG—atherosclerosis	1.93e-06	1.9e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—VEGFA—atherosclerosis	1.93e-06	1.9e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GPX1—atherosclerosis	1.93e-06	1.89e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—VEGFA—atherosclerosis	1.92e-06	1.89e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—AKT1—atherosclerosis	1.92e-06	1.89e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—VEGFA—atherosclerosis	1.92e-06	1.88e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—VEGFA—atherosclerosis	1.91e-06	1.88e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—STAT3—atherosclerosis	1.91e-06	1.88e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—STAT3—atherosclerosis	1.9e-06	1.87e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—STAT3—atherosclerosis	1.9e-06	1.87e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—NOS3—atherosclerosis	1.9e-06	1.87e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—VEGFA—atherosclerosis	1.89e-06	1.86e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—STAT3—atherosclerosis	1.89e-06	1.86e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—VEGFA—atherosclerosis	1.89e-06	1.86e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PTGS2—atherosclerosis	1.89e-06	1.85e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—IL6—atherosclerosis	1.88e-06	1.85e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—NOS3—atherosclerosis	1.88e-06	1.85e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CD36—atherosclerosis	1.88e-06	1.84e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—STAT3—atherosclerosis	1.87e-06	1.84e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—STAT3—atherosclerosis	1.87e-06	1.84e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PPARG—atherosclerosis	1.87e-06	1.84e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—MAPK3—atherosclerosis	1.85e-06	1.82e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—INS—atherosclerosis	1.83e-06	1.8e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—MAPK3—atherosclerosis	1.82e-06	1.79e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—MAPK3—atherosclerosis	1.82e-06	1.79e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—AKT1—atherosclerosis	1.81e-06	1.78e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—MAPK3—atherosclerosis	1.81e-06	1.78e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—MAPK3—atherosclerosis	1.81e-06	1.78e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—TGFB1—atherosclerosis	1.8e-06	1.77e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—MAPK3—atherosclerosis	1.79e-06	1.76e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—MAPK3—atherosclerosis	1.78e-06	1.76e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—MTHFR—atherosclerosis	1.78e-06	1.75e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—IL6—atherosclerosis	1.77e-06	1.74e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—TGFB1—atherosclerosis	1.77e-06	1.74e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—TGFB1—atherosclerosis	1.76e-06	1.74e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—TGFB1—atherosclerosis	1.76e-06	1.73e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—TGFB1—atherosclerosis	1.75e-06	1.72e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PPARA—atherosclerosis	1.74e-06	1.72e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—AKT1—atherosclerosis	1.74e-06	1.71e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—TGFB1—atherosclerosis	1.74e-06	1.71e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PTGS2—atherosclerosis	1.73e-06	1.71e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—TGFB1—atherosclerosis	1.73e-06	1.7e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PTGS2—atherosclerosis	1.72e-06	1.69e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—AGT—atherosclerosis	1.69e-06	1.66e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—ALB—atherosclerosis	1.68e-06	1.65e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—APOE—atherosclerosis	1.65e-06	1.63e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—AKT1—atherosclerosis	1.64e-06	1.62e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CAV1—atherosclerosis	1.64e-06	1.61e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—APOA1—atherosclerosis	1.64e-06	1.61e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—AKT1—atherosclerosis	1.63e-06	1.61e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—NOS3—atherosclerosis	1.61e-06	1.58e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—IL6—atherosclerosis	1.54e-06	1.52e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—IL6—atherosclerosis	1.53e-06	1.51e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.49e-06	1.47e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PTGS2—atherosclerosis	1.47e-06	1.45e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—IL6—atherosclerosis	1.47e-06	1.44e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—AKT1—atherosclerosis	1.46e-06	1.43e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PPARG—atherosclerosis	1.44e-06	1.42e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—AKT1—atherosclerosis	1.42e-06	1.4e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—AKT1—atherosclerosis	1.42e-06	1.39e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—INS—atherosclerosis	1.41e-06	1.39e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—AKT1—atherosclerosis	1.36e-06	1.33e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IL6—atherosclerosis	1.35e-06	1.33e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IL6—atherosclerosis	1.33e-06	1.31e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IL6—atherosclerosis	1.33e-06	1.31e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IL6—atherosclerosis	1.33e-06	1.3e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IL6—atherosclerosis	1.32e-06	1.3e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IL6—atherosclerosis	1.31e-06	1.29e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IL6—atherosclerosis	1.3e-06	1.28e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—ALB—atherosclerosis	1.3e-06	1.27e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—AKT1—atherosclerosis	1.25e-06	1.23e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—NOS3—atherosclerosis	1.24e-06	1.22e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—AKT1—atherosclerosis	1.23e-06	1.21e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—AKT1—atherosclerosis	1.23e-06	1.21e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—AKT1—atherosclerosis	1.23e-06	1.21e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—AKT1—atherosclerosis	1.23e-06	1.21e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—AKT1—atherosclerosis	1.22e-06	1.2e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—AKT1—atherosclerosis	1.22e-06	1.2e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—AKT1—atherosclerosis	1.21e-06	1.19e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—AKT1—atherosclerosis	1.2e-06	1.18e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.13e-06	1.12e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—AKT1—atherosclerosis	1.06e-06	1.04e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—AKT1—atherosclerosis	9.48e-07	9.32e-06	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—AKT1—atherosclerosis	8.72e-07	8.57e-06	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—AKT1—atherosclerosis	8.64e-07	8.5e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—AKT1—atherosclerosis	7.38e-07	7.26e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—AKT1—atherosclerosis	5.7e-07	5.61e-06	CbGpPWpGaD
